Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
measles, mumps, and rubella vaccine + yellow fever vaccine
- Development stage
- Unknown
- Lead developer
- Shanghai Institute of Biological Products
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
This refers to the co-administration or combination of the Measles, Mumps, and Rubella (MMR) vaccine and the Yellow Fever vaccine, specifically those developed by the Serum Institute of India (SII). The MMR component (often branded as Tresivac) is a live attenuated vaccine containing the Edmonston-Zagreb measles strain, the L-Zagreb mumps strain, and the Wistar RA 27/3 rubella strain. The Yellow Fever component is a live attenuated vaccine derived from the 17D-204 strain. This combination is primarily used in pediatric immunization programs in endemic regions to protect against all four viral diseases simultaneously. Clinical studies have focused on the safety and immunogenicity of giving these two live vaccines at the same visit, ensuring that co-administration does not result in significant immune interference.
- Brand names
- Tresivac
- Other names
- MMR + YF vaccineMMR and Yellow Fever vaccine co-administrationSIBP mmr vaccine + yellow fever vaccine
Beyond the preview
Go deeper on measles, mumps, and rubella vaccine + yellow fever vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on measles, mumps, and rubella vaccine + yellow fever vaccine.